Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total Pastilles have overtaken oil as the second most prescribed dosage form among the 18-44 age demographic, […]

Pastilles have overtaken oil as the second most prescribed dosage form among the 18-44 age demographic, latest Special Access Scheme figures have shown.

#PastillesOvertakeOil #SASBTrend #CannabizDosageShift #MedicinalCannabiz

www.cannabiz.com.au/pastilles-ov...

SAS-B approvals slow in August but pastille scripts continue to rise Pastilles are edging closer to becoming the second most prescribed dosage form through the Special Access Scheme after showing further growth.

Pastilles are edging closer to becoming the second most prescribed dosage form through the Special Access Scheme (SAS) after showing further growth, latest figures have shown.

#PastillesOnTheRise #SASBUsageTrends #CannabizDosageShift

www.cannabiz.com.au/august-sas-b...